• Aucun résultat trouvé

[PDF] Top 20 A broadly neutralizing human monoclonal antibody is effective against H7N9

Has 10000 "A broadly neutralizing human monoclonal antibody is effective against H7N9" found on our website. Below are the top 20 most common "A broadly neutralizing human monoclonal antibody is effective against H7N9".

A broadly neutralizing human monoclonal antibody is effective against H7N9

A broadly neutralizing human monoclonal antibody is effective against H7N9

... for a mAb for use as treatment combined with oseltamivir or zanamivir for severe influenza ...of a neutralizing mAb that could provide a therapeutic adjunct for diverse strains that are both ... Voir le document complet

7

Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody

Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody

... lymphocytes is an effector function held by some but not all bnAbs. Antibody- dependent cellular cytotoxicity (ADCC) is mediated through the binding of the Fc portion of the antibody to Fc ... Voir le document complet

25

Peptide-Based Vaccination for Antibody Responses Against HIV

Peptide-Based Vaccination for Antibody Responses Against HIV

... HIV-1 is responsible for a global pandemic of 35 million people and continues to spread at a rate of >2 million new ...It is widely acknowledged that a protective vaccine would be ... Voir le document complet

12

IgA dominates the early neutralizing antibody response to SARS-CoV-2

IgA dominates the early neutralizing antibody response to SARS-CoV-2

... which is more likely to occur in damaged lung tissue (31, 32). A clonal relationship has been shown between serum and mucosal antigen-specific IgA ...it is possible that plasma IgA antibodies could ... Voir le document complet

15

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients

... (ATL) is an aggressive lymphoid proliferative disease that exists under diverse clinical forms ranging from chronic to ...cells, human T-cell lymphotropic virus type 1 (HTLV-1) infected cells constitutively ... Voir le document complet

2

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

... Among a cohort of chronically HIV-1-infected patients, naı¨ve to antiretroviral therapy, we identified a patient (SA003) who showed high level of serum bnAbs, as assessed on a panel of 9 HIV-1 ... Voir le document complet

25

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

... robust antibody responses in many vaccines, is a Th2-polarizing ...both a Th1-type cytokine response, and inducing an antibody response dominated by ...protective antibody, with ... Voir le document complet

11

Boosting regulatory T-cell function with the humanized CD4-specific humanized monoclonal antibody Tregalizumab (BT-061)

Boosting regulatory T-cell function with the humanized CD4-specific humanized monoclonal antibody Tregalizumab (BT-061)

... Figure 1 Tregalizumab (BT-061) activates Treg in vitro. Tregalizumab binds the extracellular domain 2 (D 2 ) of the CD4 molecule. Treg suppression activity is then enhanced, possibly through increased LAP ... Voir le document complet

2

Single-domain antibodies represent novel alternatives to monoclonal antibodies as targeting agents against the human papillomavirus 16 E6 protein

Single-domain antibodies represent novel alternatives to monoclonal antibodies as targeting agents against the human papillomavirus 16 E6 protein

... 21 monoclonal antibodies (mAbs) benefit from greater therapeutic specificity and longer intracellular half-lives than siRNA [ 22 ...elicited a notable restoration of p53 protein levels [ 20 , 26 ] and that ... Voir le document complet

22

Targeting and killing glioblastoma with monoclonal antibody to
O-acetyl GD2 ganglioside

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside

... using a MTT assay (Figure 3, left column panels). We included a control antibody to ensure that the observed results were antigen ...control antibody- treated cells (Figure ...the ... Voir le document complet

15

The biochemical dynamics of monoclonal antibody production in high density perfused fermentors

The biochemical dynamics of monoclonal antibody production in high density perfused fermentors

... The amino acid-to-protein mass balance fails to close under conditions favoring high IgG secretion. At the high cell densities examined at steady-state, when the IgG[r] ... Voir le document complet

218

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model

... (GVHD) is a major complication of allogeneic bone marrow transplantation (BMT), used to treat hematological ...response is often necessary to eliminate residual malignant cells, an effect referred to ... Voir le document complet

11

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model

... (GVHD) is a major complication of allogeneic bone marrow transplantation (BMT), used to treat hematological ...response is often necessary to eliminate residual malignant cells, an effect referred to ... Voir le document complet

11

Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics

Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics

... or a biosimilar to a reference pro- duct) is highly ...as a reference database for mAb NMR studies in development, quality control, and post-licensure supervi- sion of the ...into a ... Voir le document complet

15

Comparison of conjugation procedures for the preparation of monoclonal antibody-enzyme conjugates

Comparison of conjugation procedures for the preparation of monoclonal antibody-enzyme conjugates

... As far as global conjugate activity was concerned, Nakane's technique (tested on three antibodies) provided slightly more efficient conjugates in terms of initial IgG input, while Tijssen's conditions proved superior in ... Voir le document complet

10

Prescribed regimen is effective.

Prescribed regimen is effective.

... We don’t understand how a signed consent form is of value as regards its authenticity. We believe journals should place more trust in authors’ attestation of consent. Forms could be archived in the ... Voir le document complet

4

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120

... to a CD4 mimic, as immunogens in llamas, we selected a panel of broadly neutralizing single-domain antibodies that bind either to the CD4 or to the co-receptor binding sites (CD4BS and CoRBS, ... Voir le document complet

2

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

... PHH is indeed possible via CLDN6 (even at low expression levels), we expected that addition of a CLDN6-speci fic antibody would enhance the antiviral potency of ...used a previously described ... Voir le document complet

11

A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.

A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.

... the antibody-producing ...to human CD81 expressed on the cell surface of CHO cells transfected with ...JS81 antibody was obtained from BD ...CBH23, a kind gift from S.K.H. Foung) mAbs and ... Voir le document complet

12

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet

34

Show all 10000 documents...